These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5589523)

  • 1. Further studies on the transplantation of lesions in hepatic carcinogenesis in rats given 2-(diacetamido)fluorene.
    Reuber MD; Odashima S
    Gan; 1967 Dec; 58(6):513-20. PubMed ID: 5589523
    [No Abstract]   [Full Text] [Related]  

  • 2. The cellular analysis of liver carcinogenesis. V. Ultrastructural alterations within hepatocellular carcinoma induced by ethionine.
    Merkow LP; Epstein SM; Slifkin M; Farber E; Pardo M
    Lab Invest; 1972 Mar; 26(3):300-5. PubMed ID: 4335732
    [No Abstract]   [Full Text] [Related]  

  • 3. The cellular analysis of liver carcinogenesis: ultrastructural alterations within hyperplastic liver nodules induced by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Caito BJ; Bartus B
    Cancer Res; 1967 Sep; 27(9):1712-21. PubMed ID: 6051282
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular analysis of liver carcinogenesis. 3. Comparison of the ultrastructure of hyperplastic liver nodules and hepatocellular carcinomas induced in rat liver by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Farber E; Pardo M; Bartus B
    J Natl Cancer Inst; 1969 Jul; 43(1):33-63. PubMed ID: 4307705
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.
    Epstein S; Ito N; Merkow L; Farber E
    Cancer Res; 1967 Sep; 27(9):1702-11. PubMed ID: 4293077
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of alpha-benzene hexachloride on 2-fluorenylacetamide carcinogenesis in rats.
    Hiasa Y; Ohshima M; Ohmori T; Murata Y
    Gan; 1978 Jun; 69(3):423-6. PubMed ID: 78868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of hyperplasia in hepatic carcinogenesis].
    Pyllvere EI
    Vestn Akad Med Nauk SSSR; 1978; (2):75-7. PubMed ID: 206067
    [No Abstract]   [Full Text] [Related]  

  • 8. The content of the principal protein target of a hepatic carcinogen in liver tumors.
    Mott DM; Sani BP; Sorof S
    Cancer Res; 1973 Nov; 33(11):2721-5. PubMed ID: 4355980
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinoma after malignant conversion in vitro of epithelial-like cells from rat liver following exposure to chemical carcinogens.
    Williams GM; Elliott JM; Weisburger JH
    Cancer Res; 1973 Mar; 33(3):606-12. PubMed ID: 4689906
    [No Abstract]   [Full Text] [Related]  

  • 10. The cellular analysis of liver carcinogenesis. VI. Growth and ultrastructural characteristics of n-2-fluorenylacetamide hyperplastic liver nodule cells grown in vitro.
    Slifkin M; Merkow LP; Epstein SM; Pardo M
    Arch Pathol; 1972 Jul; 94(1):1-10. PubMed ID: 4338214
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential morphologic changes in aflatoxin B carcinogenesis in the rat.
    Newberne PM; Wogan GN
    Cancer Res; 1968 Apr; 28(4):770-81. PubMed ID: 4296938
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of 3-methylcholanthrene on liver carcinogenesis in rats ingesting DL-ethionine, 3'-methyl-4-dimethylaminoazobenzene, and N-2-fluorenylacetamide.
    Marugami M; Ito N; Konishi Y; Hiasa Y; Farber E
    Cancer Res; 1967 Nov; 27(11):2011-9. PubMed ID: 4965303
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantable malignant cholangiocarcinoma from hamster liver.
    Glaser OG; Newberne PM; Gabliks J; Friedman L
    Arch Environ Health; 1971 Aug; 23(2):137-41. PubMed ID: 4326835
    [No Abstract]   [Full Text] [Related]  

  • 14. MORPHOLOGIC AND BIOLOGIC CORRELATION OF LESIONS OBTAINED IN HEPATIC CARCINOGENESIS IN A X C RATS GIVEN 0.025 PERCENT N-2-FLUORENYLDIACETAMIDE.
    REUBER MD; FIRMINGER HI
    J Natl Cancer Inst; 1963 Dec; 31():1407-29. PubMed ID: 14087658
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of malignant tumors in mice fed N,N'-(fluoren-2,7-ylene)bis-acetylamine.
    Takayama S; Inui N
    Gan; 1967 Apr; 58(2):193-8. PubMed ID: 6052560
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H; Verney E
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on chromatin. II. Effects of carcinogens and hormones on rat liver chromatin.
    Sporn MB; Dingman CW
    Cancer Res; 1966 Dec; 26(12):2488-95. PubMed ID: 4959456
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceleration of hepatocarcinogenesis of 2,7-bis(acetamido)fluorene by carbon tetrachloride and time relation of treatment.
    Kozuka S; Sassa R
    Gan; 1976 Apr; 67(2):141-5. PubMed ID: 184004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting effect of reserpine and female sensitivity in hepatic tumor induction with 2,7-diacetamidofluorene in SMA-Ms strain mice.
    Kozuka S
    Cancer Res; 1970 May; 30(5):1384-6. PubMed ID: 5426940
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of transplantable liver tumors in DBF mice after oral administration of n,n'-2,7-fluorenylenebisacetamide.
    Takayama S
    J Natl Cancer Inst; 1968 Mar; 40(3):629-41. PubMed ID: 5644205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.